mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
Vorinostat |
FIMM |
pan-cancer |
AAC |
0.062 |
0.7 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
-0.065 |
0.7 |
mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.02 |
0.7 |